Prevalence of ISAba1 in epidemiologically unrelated Acinetobacter baumannii clinical isolates

被引:39
作者
Ruiz, Marc
Marti, Sara
Fernandez-Cuenca, Felipe
Pascual, Alvaro
Vila, Jordi [1 ]
机构
[1] Univ Barcelona, Hosp Clin, Fac Med, Ctr Diagnost Biomed,Serv Microbiol,IDIBAPS, E-08036 Barcelona, Spain
[2] Hosp Virgen Macarena, Microbiol Serv, Seville, Spain
关键词
insertion sequence; resistance; ceftazidime; Acinetobacter baumannii;
D O I
10.1111/j.1574-6968.2007.00828.x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Seventy-five Acinetobacter baumannii strains belonging to different pulsetypes, plus one ceftazidime-susceptible strain, from a pulsetype in which all strains were resistant, were included in this study. The minimum inhibitory concentration of ceftazidime was determined by the microdilution method. The bla(ADC)-like gene, the ISAba1 element and the ISAba1 located in the bla(ADC)-like promoter were detected by PCR. The objective of the study was to determine the prevalence of ISAba1 in a collection of epidemiologically unrelated A. baumannii clinical isolates. The bla(ADC)-like gene was detected in 74 (97.3%) out of the 76 strains analysed. In these 74 strains, 51 (69%) were positive for the IS element and it was not detected in 23 (31%) strains. Among the A. baumannii strains containing the IS element, 40 (78.4%) had the IS element located in the promoter region of the bla(ADC)-like gene. In a high percentage of A. baumannii clinical isolates carrying the ISAba1, this is inserted into the promoter region of the bla(ADC)-like gene. In addition, two clinical isolates belonging to the same pulsetype, one with and one without the ISAba1, can be found in the clinical setting, suggesting the potential acquisition or loss of this genetic element in the hospital environment.
引用
收藏
页码:63 / 66
页数:4
相关论文
共 21 条
[1]   Molecular characterization of the gene encoding a new AmpC β-lactamase in Acinetobacter baylyi [J].
Beceiro, Alejandro ;
Perez-Llarena, Francisco J. ;
Perez, Astrid ;
del Mar Tomas, Ma ;
Fernandez, Ana ;
Mallo, Susana ;
Villanueva, Rosa ;
Bou, German .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (05) :996-1000
[2]   Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].
BergogneBerezin, E ;
Towner, KJ .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+
[3]   Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii [J].
Bou, G ;
Martínez-Beltrán, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :428-432
[4]  
Clinical and Laboratory Standards Institute. (formerly NCCLS), 2000, METH DIL ANT SUSC TE
[5]   AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains [J].
Corvec, S ;
Caroff, N ;
Espaze, E ;
Giraudeau, C ;
Drugeon, H ;
Reynaud, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (04) :629-635
[6]   Distribution of β-lactamases in Acinetobacter baumannii clinical isolates and the effect of Syn 2190 (AmpC inhibitor) on the MICs of different β-lactam antibiotics [J].
Danes, C ;
Navia, MM ;
Ruiz, J ;
Marco, F ;
Jurado, A ;
de Anta, MTJ ;
Vila, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (02) :261-264
[7]   Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain.: A nationwide study:: GEIH-Ab project (2000) [J].
Fernández-Cuenca, F ;
Pascual, A ;
Ribera, A ;
Vila, J ;
Bou, G ;
Cisneros, JM ;
Rodríguez-Baño, J ;
Pachón, J ;
Marítinez-Martínez, L .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2004, 22 (05) :267-271
[9]   Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936) [J].
Henwood, CJ ;
Gatward, T ;
Warner, M ;
James, D ;
Stockdale, MW ;
Spence, RP ;
Towner, KJ ;
Livermore, DM ;
Woodford, N .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (03) :479-487
[10]   Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 β-lactamase:: Defining a unique family of class C enzymes [J].
Hujer, KM ;
Hamza, NS ;
Hujer, AM ;
Perez, F ;
Helfand, MS ;
Bethel, CR ;
Thomson, JM ;
Anderson, VE ;
Barlow, M ;
Rice, LB ;
Tenover, FC ;
Bonomo, RA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) :2941-2948